High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy Meeting Abstract


Authors: Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
Abstract Title: High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385005407
PROVIDER: wos
Notes: Meeting Abstract: 2695 -- Source: Wos